{"id":"W4407302463","doi":"10.1136/jitc-2024-010584","title":"TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial","year":2025,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Healthcare KGaA","keywords":"Medicine; Pharmacodynamics; Pharmacokinetics; Tolerability; TIGIT; Gastroenterology; Internal medicine; Neutropenia; Chills; Pharmacology; Antibody; Oncology; Immunology; Chemotherapy; T cell; Adverse effect; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009130251,0.001375971,0.001749513,0.0003922163,0.0003337567,0.0009553641,0.0006875683,0.0008749115,0.003504764],"category_scores_gemma":[0.0005725332,0.0004134719,0.001049869,0.000409255,0.0005728828,0.0007508419,0.0002887303,0.002594128,0.0007763925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009848817,"about_ca_system_score_gemma":0.001119131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009215693,"about_ca_topic_score_gemma":0.002673208,"domain_scores_codex":[0.9998137,0.00007029276,0.000009885268,0.00003614764,0.0000201269,0.00004982265],"domain_scores_gemma":[0.9996221,0.00005346163,0.00007824609,0.00002561289,0.00002352046,0.0001969802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6877817,0.05434028,0.005011184,0.001962667,0.002345334,0.000393683,0.0005869509,0.004798486,0.04475492,0.0004035241,0.008496052,0.1891252],"study_design_scores_gemma":[0.601274,0.3770106,0.009567626,0.00009319384,0.0008017283,0.0005037065,0.00009775716,0.00182659,0.003975397,0.0002973138,0.004509507,0.00004256613],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933274,0.00343771,0.000205025,0.0003724582,0.00009713075,0.0007166837,0.0004801264,0.00008597744,0.001277605],"genre_scores_gemma":[0.9918883,0.002912776,0.0007215469,0.0006180276,0.0001296477,0.0007725168,0.001058216,0.00002221122,0.001876767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003504764,"threshold_uncertainty_score":0.01172459,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01596827262127317,"score_gpt":0.3840873400655939,"score_spread":0.3681190674443207,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}